ONORATO, LORENZO
 Distribuzione geografica
Continente #
EU - Europa 676
NA - Nord America 484
AS - Asia 122
SA - Sud America 13
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.296
Nazione #
US - Stati Uniti d'America 478
IE - Irlanda 332
IT - Italia 141
CN - Cina 57
SG - Singapore 53
GB - Regno Unito 51
DE - Germania 39
UA - Ucraina 35
FR - Francia 27
GR - Grecia 19
FI - Finlandia 18
MX - Messico 5
SE - Svezia 5
BO - Bolivia 4
BR - Brasile 4
KR - Corea 4
BE - Belgio 3
IN - India 3
BD - Bangladesh 2
CZ - Repubblica Ceca 2
PE - Perù 2
AR - Argentina 1
CO - Colombia 1
ES - Italia 1
EU - Europa 1
HK - Hong Kong 1
IR - Iran 1
MK - Macedonia 1
PA - Panama 1
RS - Serbia 1
RU - Federazione Russa 1
TW - Taiwan 1
VE - Venezuela 1
Totale 1.296
Città #
Dublin 332
Jacksonville 67
Roxbury 32
Ann Arbor 31
Princeton 31
Bremen 30
Chandler 29
Singapore 26
Beijing 19
New York 19
Houston 18
Cambridge 16
Ashburn 15
Medford 15
Milan 14
Woodbridge 11
Los Angeles 10
Naples 10
Ariano Irpino 8
Caserta 8
Des Moines 8
Rome 8
Helsinki 6
Boardman 5
Guadalajara 5
Jinan 5
Washington 5
Wilmington 5
Zhengzhou 5
Bagheria 4
Hangzhou 4
La Paz 4
Redwood City 4
Seoul 4
Auburn Hills 3
Brussels 3
Guangzhou 3
Lappeenranta 3
Monte San Pietro 3
Munich 3
Seattle 3
Capua 2
Chittagong 2
Dearborn 2
Frankfurt am Main 2
Hebei 2
Lima 2
Marco 2
Mountain View 2
Nanjing 2
Napoli 2
Norwalk 2
Salerno 2
San Nicola la Strada 2
Sermoneta 2
Shanghai 2
Afragola 1
Amorosi 1
Aversa 1
Belgrade 1
Bogotá 1
Boydton 1
Brno 1
Buenos Aires 1
Casoria 1
Changsha 1
Clifton 1
Düsseldorf 1
Eboli 1
Elk Grove 1
Espoo 1
Fuzhou 1
Gunzenhausen 1
Henderson 1
Hong Kong 1
Hyderabad 1
Kovrov 1
Kunming 1
Lanzhou 1
London 1
Luzzano 1
Nanchang 1
Palagiano 1
Pamplona 1
Paris 1
Providence 1
Pune 1
Rio Saliceto 1
Sacramento 1
Sant'anastasia 1
Shenyang 1
Simi Valley 1
Stockholm 1
Striano 1
Taipei 1
Taizhou 1
Tappahannock 1
Tianjin 1
Zanjan 1
Totale 907
Nome #
Micro-RNAs in hepatitis B virus-related chronic liver diseases and hepatocellular carcinoma 85
Patologie virali tropicali (Flavivirus, Filovirus, Arenavirus, Bunyavirus, Togavirus: Chikungunya, 67
Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis 52
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf 50
Eighteen-month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy 50
Clinical significance of hepatitis B surface antigen mutants 49
Role of genetic polymorphisms in hepatitis C virus chronic infection 46
EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS 46
Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features 45
Liver microRNA hsa-miR-125a-5p may exert an oncosuppressor effect on hepatocellular carcinoma (HCC). 41
Low prevalence of HTLV1/2 infection in a population of immigrants living in southern Italy 39
HBV molecular epidemiology and clinical condition of immigrants living in Italy 38
Hepatitis B virus and hepatitis C virus infection in healthcare workers 37
Clinical findings of HCV chronic infection in undocumented immigrants and low-income refugees in three areas of southern Italy 37
Evaluation of lipid profile in HIV naive patients, treated by TAF-based regimens. 36
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 36
Role of occult hepatitis B virus infection in chronic hepatitis C 35
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 34
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 33
Risk and prevention of hepatitis b virus reactivation during immunosuppression for non-oncological diseases 32
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 29
Prevalence of occult HBV infection in Western countries 23
Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study 22
Epidemiology, Mechanisms of Resistance and Treatment Algorithm for Infections Due to Carbapenem-Resistant Gram-Negative Bacteria: An Expert Panel Opinion 22
Virological factors associated with failure to the latest generation of direct acting agents (Daa) and re-treatment strategy: A narrative review 22
Impact of an education‐based antimicrobial stewardship program on the appropriateness of antibiotic prescribing: Results of a multicenter observational study 21
Dynamics of Lipid Profile in Antiretroviral-Naïve HIV-Infected Patients, Treated with TAF-Based Regimens: A Multicenter Observational Study 21
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 20
Standard versus high dose of rifampicin in the treatment of pulmonary tuberculosis: a systematic review and meta-analysis 19
HDV infection in immigrant populations 19
Epidemiology and management of hepatitis C virus infections in immigrant populations 19
Role of occult hepatitis B virus infection in chronic hepatitis C 19
Beta-lactam monotherapy or combination therapy for bloodstream infections or pneumonia due to Pseudomonas aeruginosa: a meta-analysis 18
Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report 17
The effect of an antimicrobial stewardship programme in two intensive care units of a teaching hospital: an interrupted time series analysis 17
Role of genetic polymorphisms in hepatitis C virus chronic infection 17
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 16
Epidemiological, Clinical and Microbiological Characteristics of Patients with Bloodstream Infections Due to Carbapenem-Resistant K. Pneumoniae in Southern Italy: A Multicentre Study 16
DAA-based treatment for HIV-HCV-coinfected patients: analysis of factors of sustained virological response in a real-life study 16
The impact of the sars‐cov2 pandemic on a persuasive educational antimicrobial stewardship program in a university hospital in southern italy: A pre‐post study 16
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 15
Hepatitis D virus infection in a large cohort of immigrants in southern Italy: a multicenter, prospective study 14
Prevalence and Therapeutic Management of Infections by Multi-Drug-Resistant Organisms (MDROs) in Patients with Liver Cirrhosis: A Narrative Review 14
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 10
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study 7
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 7
Prevalence and Epidemiological and Clinical Features of Bacterial Infections in a Large Cohort of Patients Hospitalized for COVID-19 in Southern Italy: A Multicenter Study 6
Effectiveness of test-and-treat model with direct-acting antiviral for hepatitis C virus infection in migrants: a prospective interventional study in Italy 6
Characterization of hepatitis virus co-infections in a cohort of immigrants living in southern Italy 6
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort 5
A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy 5
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 3
Totale 1.375
Categoria #
all - tutte 8.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202093 0 0 0 18 17 6 20 8 4 11 8 1
2020/2021145 0 6 9 4 38 23 22 14 2 5 21 1
2021/2022170 0 2 1 1 49 1 21 4 5 10 12 64
2022/2023445 35 7 9 7 67 9 2 28 271 1 5 4
2023/2024294 22 15 21 25 95 27 4 8 5 13 10 49
2024/202538 5 10 1 22 0 0 0 0 0 0 0 0
Totale 1.375